Efficacy and Safety of Camrelizumab Plus Rivoceranib and Local Therapy for Hepatocellular Carcinoma With Lung Metastases (CAPLocal) : A Multicentre, Single-Arm,Prospective Cohort Study
NCT07482670
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Hepatecellular Carcinoma
Sponsor
Xiangya Hospital of Central South University